Fatigue is common in the first weeks, often related to reduced caloric intake as appetite suppression takes effect
Dal Negro, R., Turco, P., Pomari, C., and De Conti, F
How Semaglutide Works Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it works by mimicking the natural hormone GLP-1 found in the body
(2021) Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine
Eli Lilly said that obesity increases the risk of diabetes and many metabolic diseases, so treating obesity can improve people's health by reducing the chance of developing metabolic diseases and related complications